CHA₂DS₂-VASc Risk Assessment Score
Der CHA₂DS₂-VASc-Score schätzt das Schlaganfallrisiko bei Patienten mit nicht-valvulärem Vorhofflimmern (AF) ab, um den potenziellen Nutzen einer oralen Antikoagulation zu beurteilen.
• 0 Punkte: Geringes Risiko (Low Risk)
• 1 Punkt: Mittleres Risiko (Intermediate Risk)
• ≥ 2 Punkte: Hohes Risiko (High Risk)
Rechtlicher Hinweis: Dieser Rechner dient ausschließlich zu Informationszwecken und als klinische Orientierungshilfe. Er ersetzt keine eigenständige ärztliche Beurteilung und medizinische Diagnose.
Referenzen:
1. Lip GY, Nieuwlaat R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010; 137: 263-72.
2. Lip GY. Using the CHADS2 and CHA2DS2-VASc scores for stroke risk prediction as well as the identification of stroke outcomes and cardiac complications in patients with and without atrial fibrillation. Cerebrovasc Dis. 2013; 36: 281-2.
3. Maheshwari A, Norby FL, et al. Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score. Circulation. 2019; 139: 180-91.
4. Hart RG, Pearce LA, et al. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine. 2007; 146: 857-67.
5. Olesen JB, Lip GY, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011; 342: d124.
6. Chao TF, Liu CJ, et al. Comparisons of CHADS2 and CHA2DS2-VASc scores for stroke risk stratification in atrial fibrillation: Which scoring system should be used for Asians? Heart rhythm : the official journal of the Heart Rhythm Society. 2016; 13: 46-53.
7. Friberg L, Rosenqvist M, et al. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. European heart journal. 2012; 33: 1500-10.
8. Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314-414.